| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXCM | Common Stock | Sale | $295,794 | -806 | -21% | $366.99 | 3,110 | 03 Jun 2021 | Direct | F1, F2 |
| holding | DXCM | Common Stock | 7,900 | 03 Jun 2021 | by Trust |
| Id | Content |
|---|---|
| F1 | On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. |
| F2 | Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. |